MSLE Satellos Bioscience Inc.
Price Chart
Executive Summary
Satellos Bioscience announced it will present at the Bloom Burton & Co. Healthcare Investor Conference on April 21, 2026, where CEO Frank Gleeson will host a presentation and management will hold one-on-one meetings. This is a routine investor relations update with no new financial or clinical data disclosed.
Actionable Insight
Traders should monitor the webcast for any unexpected commentary on SAT-3247 clinical trials (BASECAMP/TRAILHEAD) or pipeline updates, but no material announcements are expected. Increased investor engagement could support sentiment ahead of future catalysts.
Key Facts
- Satellos Bioscience (MSLE) will participate in the Bloom Burton & Co. Healthcare Investor Conference on April 21-22, 2026.
- CEO Frank Gleeson will deliver a presentation on April 21 at 11:30 a.m. ET, and CFO Liz Williams will join one-on-one meetings.
- The presentation will be webcast and available on the company's website, but no new clinical or financial information will be released.
- This 6-K filing is solely to attach the press release announcing the conference participation.
Financial Impact
No immediate financial impact; presentation may improve investor visibility.
Risk Factors
- Low attendance or lack of follow-up interest from investors could limit the event's effectiveness.
- Failure to provide new data or guidance may result in minimal stock price movement.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-002337 |
| Exhibit: exh_991.htm | 0001171843-26-002337 |
| Document: 0001171843-26-002337-index-headers.html | 0001171843-26-002337 |
| Document: 0001171843-26-002337-index.html | 0001171843-26-002337 |
| Document: 0001171843-26-002337.txt | 0001171843-26-002337 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 20, 2026
3d ago
|
6-K
| — | awaiting T+20 | — | — |
|
May 15, 2026
8d ago
|
6-K
| — | awaiting T+20 | — | — |
|
May 15, 2026
8d ago
|
Press Release
| — | awaiting T+20 | — | — |
|
Apr 9, 2026
6w ago
|
6-K
| $6.20 $7.70 | ▲ +24.19% | ▲ +16.63% | $6.75 (+8.87%) |
|
Mar 27, 2026
8w ago
|
6-K
| $6.19 $7.16 | ▲ +15.67% | ▲ +2.93% | $6.75 (+9.05%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access